Elizabeth Bayliss to Cognitive Dysfunction
This is a "connection" page, showing publications Elizabeth Bayliss has written about Cognitive Dysfunction.
Connection Strength
2.595
-
Clinical Factors Associated With Nonadherence to Chronic Medications in People With Cognitive Impairment. Sr Care Pharm. 2022 May 01; 37(5):191-199.
Score: 0.772
-
Perspectives on Deprescribing Communication in Primary Care. J Gen Intern Med. 2021 04; 36(4):1122.
Score: 0.717
-
Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden. Drugs Aging. 2018 03; 35(3):223-232.
Score: 0.579
-
Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed. Age Ageing. 2023 01 08; 52(1).
Score: 0.203
-
The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial. Trials. 2020 Jun 18; 21(1):542.
Score: 0.170
-
Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study. Drugs Aging. 2019 03; 36(3):289-297.
Score: 0.155